The U.S. Food and Drug Administration granted full approval Monday to the COVID-19 vaccine developed by Pfizer and BioNTech, whose shots are now the first to move beyond emergency status since the pandemic began.
The U.S. Food and Drug Administration granted full approval Monday to the COVID-19 vaccine developed by Pfizer and BioNTech, whose shots are now the first to move beyond emergency status since the pandemic began.